Professor Sallie Lamb from Warwick Medical School has been appointed as the new chair of the national Health Technology Assessment (HTA) Clinical Evaluation and Trials Board.

Professor Lamb is Professor of Rehabilitation and Director of the Warwick Clinical Trials Unit, based at the University of Warwick.

The HTA is a programme of the National Institute for Health Research (NIHR) and produces research information about the effectiveness, costs, and broader impact of health technologies for those who use, manage and provide care in the NHS.

Professor Lamb will take up her new position on 1 January 2010 for a three-year period. The HTA Clinical Evaluation and Trials Board considers proposals from researcher-initiated open and themed calls.

Professor Lamb has been a member of the HTA Commissioning Board for a number of years, and has led a number of HTA funded trials including the cognitive therapies for back pain, non-pharmacological interventions for acute whiplash, and the recently funded prevention of fall injury trial.